Old Web
English
Sign In
Acemap
>
Paper
>
20-Gy single-fraction as HDR Monotherapy For Low And Intermediate Prostate Cancer: Clinical Outcomes And Toxicity Profile
20-Gy single-fraction as HDR Monotherapy For Low And Intermediate Prostate Cancer: Clinical Outcomes And Toxicity Profile
2020
L. Larrea
V. Gonzalez
P. Antonini
M.A. Berenguer
E. López
J Bea
M.C. Baños
J. Lago
Keywords:
Prostate cancer
single fraction
Medicine
Internal medicine
Oncology
toxicity profile
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]